EP1171584A1 - Kit d'extraction d'adn magnetique pour plantes - Google Patents
Kit d'extraction d'adn magnetique pour plantesInfo
- Publication number
- EP1171584A1 EP1171584A1 EP00923575A EP00923575A EP1171584A1 EP 1171584 A1 EP1171584 A1 EP 1171584A1 EP 00923575 A EP00923575 A EP 00923575A EP 00923575 A EP00923575 A EP 00923575A EP 1171584 A1 EP1171584 A1 EP 1171584A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- kit
- positively charged
- charged groups
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000007400 DNA extraction Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 50
- 239000011324 bead Substances 0.000 claims abstract description 29
- 239000012266 salt solution Substances 0.000 claims abstract description 3
- 239000000758 substrate Substances 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- 239000003599 detergent Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 claims description 4
- 230000002934 lysing effect Effects 0.000 claims description 4
- 239000012139 lysis buffer Substances 0.000 claims description 4
- 108010067770 Endopeptidase K Proteins 0.000 claims description 3
- 108700004121 sarkosyl Proteins 0.000 claims description 3
- 239000012149 elution buffer Substances 0.000 claims description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims 3
- 230000001413 cellular effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 65
- 125000000129 anionic group Chemical group 0.000 abstract description 9
- 238000000605 extraction Methods 0.000 abstract description 9
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 abstract description 7
- 238000005349 anion exchange Methods 0.000 abstract description 7
- 108020005120 Plant DNA Proteins 0.000 abstract description 6
- 230000003993 interaction Effects 0.000 abstract description 4
- 150000002500 ions Chemical class 0.000 abstract description 3
- 108020005196 Mitochondrial DNA Proteins 0.000 abstract description 2
- 210000003763 chloroplast Anatomy 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- -1 Alkyltrimethylammonium Bromides Chemical class 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 230000009089 cytolysis Effects 0.000 description 4
- 239000006148 magnetic separator Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- JVAZJLFFSJARQM-RMPHRYRLSA-N (2r,3r,4s,5s,6r)-2-hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JVAZJLFFSJARQM-RMPHRYRLSA-N 0.000 description 1
- HEGSGKPQLMEBJL-RQICVUQASA-N (2r,3s,4s,5r)-2-(hydroxymethyl)-6-octoxyoxane-3,4,5-triol Chemical compound CCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RQICVUQASA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- WKALLSVICJPZTM-UHFFFAOYSA-N 3-[decyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O WKALLSVICJPZTM-UHFFFAOYSA-N 0.000 description 1
- DIROHOMJLWMERM-UHFFFAOYSA-N 3-[dimethyl(octadecyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O DIROHOMJLWMERM-UHFFFAOYSA-N 0.000 description 1
- QZRAABPTWGFNIU-UHFFFAOYSA-N 3-[dimethyl(octyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O QZRAABPTWGFNIU-UHFFFAOYSA-N 0.000 description 1
- GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 1
- NKOTXYPTXKUCDL-UHFFFAOYSA-N 4-(trifluoromethyl)pyrimidin-2-amine Chemical compound NC1=NC=CC(C(F)(F)F)=N1 NKOTXYPTXKUCDL-UHFFFAOYSA-N 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 101100468275 Caenorhabditis elegans rep-1 gene Proteins 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- 108010035713 Glycodeoxycholic Acid Proteins 0.000 description 1
- WVULKSPCQVQLCU-UHFFFAOYSA-N Glycodeoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 WVULKSPCQVQLCU-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- QWZLBLDNRUUYQI-UHFFFAOYSA-M Methylbenzethonium chloride Chemical compound [Cl-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 QWZLBLDNRUUYQI-UHFFFAOYSA-M 0.000 description 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- CTTQEKDKNOAZDK-WESUDHAXSA-N [3-hydroxy-2-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-undecyloxan-2-yl]oxypropyl] (Z)-octadec-9-enoate Chemical compound C(CCCCCCCCCC)C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)OC(COC(CCCCCCC\C=C/CCCCCCCC)=O)CO CTTQEKDKNOAZDK-WESUDHAXSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
- 229960000228 cetalkonium chloride Drugs 0.000 description 1
- 229940115457 cetyldimethylethylammonium bromide Drugs 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229950000405 decamethonium Drugs 0.000 description 1
- VLYJSMCZTWOMOG-UHFFFAOYSA-N decane-1-sulfonic acid;octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O.CCCCCCCCCCS(O)(=O)=O VLYJSMCZTWOMOG-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- IIGRCIRUBRDAAJ-UHFFFAOYSA-N dodecyl hydrogen sulfate octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCCCCOS(O)(=O)=O IIGRCIRUBRDAAJ-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- VUFOSBDICLTFMS-UHFFFAOYSA-M ethyl-hexadecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC VUFOSBDICLTFMS-UHFFFAOYSA-M 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 229940099347 glycocholic acid Drugs 0.000 description 1
- WVULKSPCQVQLCU-BUXLTGKBSA-N glycodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 WVULKSPCQVQLCU-BUXLTGKBSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- AKRQHOWXVSDJEF-UHFFFAOYSA-N heptane-1-sulfonic acid Chemical compound CCCCCCCS(O)(=O)=O AKRQHOWXVSDJEF-UHFFFAOYSA-N 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- PNWNIFBPBXCAPY-UHFFFAOYSA-N methyl(triactyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC[NH2+]C PNWNIFBPBXCAPY-UHFFFAOYSA-N 0.000 description 1
- 229960002285 methylbenzethonium chloride Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- GCRLIVCNZWDCDE-SJXGUFTOSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]nonanamide Chemical compound CCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO GCRLIVCNZWDCDE-SJXGUFTOSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- ZGAZPDWSRYNUSZ-UHFFFAOYSA-N nonane-1-sulfonic acid Chemical compound CCCCCCCCCS(O)(=O)=O ZGAZPDWSRYNUSZ-UHFFFAOYSA-N 0.000 description 1
- RJQRCOMHVBLQIH-UHFFFAOYSA-N pentane-1-sulfonic acid Chemical compound CCCCCS(O)(=O)=O RJQRCOMHVBLQIH-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
- XZPMQCKVOWVETG-UHFFFAOYSA-J tetrasodium;2-[(3-carboxylato-3-sulfonatopropanoyl)-octadecylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].CCCCCCCCCCCCCCCCCCN(C(CC([O-])=O)C([O-])=O)C(=O)CC(C([O-])=O)S([O-])(=O)=O XZPMQCKVOWVETG-UHFFFAOYSA-J 0.000 description 1
- HLXQFVXURMXRPU-UHFFFAOYSA-L trimethyl-[10-(trimethylazaniumyl)decyl]azanium;dibromide Chemical compound [Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C HLXQFVXURMXRPU-UHFFFAOYSA-L 0.000 description 1
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
- 229960004224 tyloxapol Drugs 0.000 description 1
- 229920001664 tyloxapol Polymers 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Definitions
- the present invention generally relates to the field of methods and kits for the extraction of DNA and specifically to methods and kits for the extraction of DNA from plants.
- Methods for extracting DNA from plants include:
- the Dellaporta method Dellaporta. S.L., et al. 1983. A plant DNA minipreparation: Version II. Plan Mol Biol Rep 1 : 19-21 , where DNA is precipitated to produce a very crude preparation, with a lot of the ethanol insoluble contaminants present in the solution.
- a variant of the Dellaporta method introduces an additional step of purifying the DNA via ultracentrifugation through a cesium chloride (CsCl) gradient for several hours or overnight.
- CsCl cesium chloride
- CTAB cetyltrimethylammonium bromide
- CTAB is a cationic detergent, which will form an insoluble complex with the DNA in the presence of low concentrations of salt, such as a 0.5 M sodium chloride (NaCl) solution.
- salt such as a 0.5 M sodium chloride (NaCl) solution.
- NaCl sodium chloride
- the original lysis solution contains about 1.4 M NaCl.
- the DNA binds with the CTAB when the NaCl concentration is decreased to 0.5 M.
- This method is also time consuming and. because the procedure does not use organic solvents, an additional step needs to be included to clean up the DNA: a final extraction with organic solvents to rid the preparation of polysaccharide and phenolic compounds.
- U.S. Patent No. 5,705.628 to Hawkins discloses the use of magnetic microparticles with a coating including functional groups, specifically carboxyl or negatively charged groups, for the purification and isolation of DNA by binding and elution.
- International Application WO 96/18731 by Deggerdal. et al. discloses a method for the isolation of nucleic acids by the binding to and elution from a solid support, preferably magnetic beads, in the presence of a detergent, preferably an anionic detergent such as SDS or SARCOSYLTM.
- U.S. Patent No. 5,650,506 to Woodard, et al. discloses the use of glass fiber membranes bearing positive surface charges for DNA purification by binding to and elution from the glass fibers.
- a commercially available method for the extraction of DNA from bacterial cells is marketed as ISOLATETM by Annovis, Inc. (catalog number 2- 0300-85).
- the protocol includes the following steps: suspending bacterial cells in a buffer (pH 8.0), lysing the cells by mixing the suspension with an alkaline - detergent solution (0.2 M NaOH, 1% SDS).
- a method and kit for the extraction of DNA from plants which quickly yields plant DNA with a high level of purity.
- the method isolates DNA (genomic, chloroplast. and/or mitochondrial DNA) using immobilized anionic groups, preferably on a chromatographic substrate or more preferably magnetic beads derivatized with anionic groups such as diethylaminoethyl (DEAE) via an anion-exchange interaction.
- the purified DNA is then eluted with ions (typically a salt solution).
- RNA can be removed by digestion with RNAse.
- the method described herein can be used with any plant material and has been demonstrated to be efficacious with the following representative types of plants: arabdopsis seedlings, barley embryos, tobacco leaves, tomato leaves, soybean hypocotylis and cultured cells, white beans hypocotylis and roots, young and old pine needles.
- the process generally includes the steps of: grinding plant material to make a tissue extract, lysing the plant cells, removing cell debris, and binding the plant DNA to an immobilized or insoluble material such as magnetic beads, where it is separated into pure form.
- plant material is first ground to a powder in liquid nitrogen and then incubated in lysis buffer (0.1 M Tris-HCl, pH 8.0, 0.1 M EDTA. pH 8.0, 0.25 M NaCl and 100 microgram/ml proteinase K) in the presence of a surfactant or nonionic detergent such as N-laurylsarcosine (SARKOSYLTM), TRITONTM or NONIDETTM P-40, which acts to solubilize cell components and lyse the cells. Representative detergents are listed in Table I.
- Cell debris is then removed by centrifugation and the supernatant, which contains the DNA and other soluble cell components, is collected.
- the DNA is then bound to an immobilized or insoluble material having anionic groups bound thereto, such as magnetic beads derivatized with DEAE. This material is mixed with the supernatant, bound to the DNA, and then removed from the supernatant using a magnetic separator.
- the beads are subsequently washed and then the DNA is preferably eluted from the beads by adding NaCl to a final concentration of 1.0 M.
- the DNA could be removed by binding to DEAE chromatographic material or filler material, which is separated by washing, centrifugation, or other methods known to those skilled in the art.
- the method and kit produces DNA of equal purity to CsCl gradient methods at yields that are equal to, or better than, the prior art, Dellaporta and CTAB methods.
- the specific problems of the Dellaporta method (use of a CsCl column), and CTAB method (use of cationic detergents), are avoided by this method.
- the method and kit also extracts and purifies the DNA more quickly than the CsCl method.
- the method including the precipitation step takes a total of approximately 2.5 hours; without the precipitation step it takes less than 2 hours (1 hour and 50 minutes) to extract and purify the plant DNA: approximately 1 hour to lyse the cells, 5 minutes to bind the DNA to the magnetic beads. 5 minutes to wash the beads, 5 minutes to separate the DNA from the beads.
- the preferred method described herein produces a very pure DNA preparation via an anion-exchange interaction where DNA is replaced as the binding species on the anion-exchange matrix by chloride ions or other negatively charged ions derived from any of a variety of salts. If a traditional anion-exchange column were used at the point where the beads are introduced, the columns would likely clog, preventing collection of bound DNA, or if the elution was effected with strong acid or base, significant levels of contaminates would co-elute with the DNA.
- the DNA bound to the beads can be thoroughly mixed with the wash solutions, contaminates are more easily removed than they are in traditional column formats, resulting in a more pure preparation. Moreover, because the DNA bound to the beads is not sheared or compressed, when pelleted, the attached DNA consists of longer and more intact strands.
- the lysis methods for plant genomic DNA and bacterial plasmid DNA are different.
- the lysis method for bacterial plasmid DNA uses alkaline conditions in the presence of anionic detergent in the form of SDS, while the lysis method for plant genomic DNA uses a nonionic detergent.
- the type of detergent used affects the remaining steps in each method. Since SDS is anionic (negatively charged, like DNA), it must be removed from the solution in the plasmid procedure before the beads are introduced, otherwise the SDS would compete for binding with the plasmid DNA on the positively charged beads. In the ISOLATETM plasmid extraction system, the SDS is removed from the solution by adding potassium acetate to form an insoluble precipitate with the chromosomal DNA.
- the aggregate of SDS with bacterial genomic DNA can be easily separated from the soluble plasmid DNA.
- no precipitation is needed prior to the binding step, because the nonionic non-charged detergent used in the methods and kits described herein does not compete with the DNA for binding sites, since the genomic DNA is the desired binding species for the DEAE groups on the beads. Therefore, the nonionic detergent does not need to be removed, whereas SDS and other anionic detergents are negatively charged and do compete with DNA for anionic binding sites and therefore would need to be removed.
- N-lauroylsarcosine at a final concentration of between 0.1 % and 10%. If desired, 25 - 200 ⁇ g of RNase A can be added at this point. Alternatively, the final resuspended pellet can be treated with RNase. Incubate 30 minutes to 1 hour at 50-60°C.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Saccharide Compounds (AREA)
Abstract
L'invention concerne un procédé et un kit pour l'extraction d'ADN de plantes, permettant de produire rapidement de l'ADN de plantes présentant un grand degré de pureté. Ledit procédé permet d'isoler de l'ADN (ADN génomique, de chloroplaste et/ou mitochondrien) au moyen de groupes anioniques immobilisés, de préférence sur un substrat chromatographique ou idéalement sur des billes magnétiques dérivées de groupes anioniques, tels que le diéthylaminoéthyle (DEAE), par une interaction à échange d'anions. L'ADN purifié est ensuite élué à l'aide d'ions (généralement une solution salée). L'ARN peut être supprimé par digestion à l'aide de Rnase.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13035399P | 1999-04-21 | 1999-04-21 | |
| US130353P | 1999-04-21 | ||
| PCT/US2000/010834 WO2000063362A1 (fr) | 1999-04-21 | 2000-04-21 | Kit d'extraction d'adn magnetique pour plantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1171584A1 true EP1171584A1 (fr) | 2002-01-16 |
Family
ID=22444292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00923575A Withdrawn EP1171584A1 (fr) | 1999-04-21 | 2000-04-21 | Kit d'extraction d'adn magnetique pour plantes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1171584A1 (fr) |
| JP (1) | JP2002541839A (fr) |
| AU (1) | AU4367500A (fr) |
| CA (1) | CA2370656A1 (fr) |
| WO (1) | WO2000063362A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102888397A (zh) * | 2012-09-25 | 2013-01-23 | 杭州硕航生物科技有限公司 | 一种利用磁珠提取全血基因组dna的试剂盒及应用 |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040121313A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in organs for transplantation |
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US8073627B2 (en) | 2001-06-26 | 2011-12-06 | Ibis Biosciences, Inc. | System for indentification of pathogens |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| AU2002359522A1 (en) | 2001-11-28 | 2003-06-10 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| JP2006516193A (ja) | 2002-12-06 | 2006-06-29 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヒトおよび動物における病原体の迅速な同定方法 |
| US8057993B2 (en) | 2003-04-26 | 2011-11-15 | Ibis Biosciences, Inc. | Methods for identification of coronaviruses |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8158354B2 (en) * | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US20050009036A1 (en) * | 2003-07-11 | 2005-01-13 | Applera Corporation | Methods and kits for obtaining nucleic acid from biological samples |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8394945B2 (en) | 2003-09-11 | 2013-03-12 | Ibis Biosciences, Inc. | Compositions for use in identification of bacteria |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| ES2641832T3 (es) | 2004-05-24 | 2017-11-14 | Ibis Biosciences, Inc. | Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| WO2006135400A2 (fr) | 2004-08-24 | 2006-12-21 | Isis Pharmaceuticals, Inc. | Procedes pour l'identification rapide d'organismes recombinants |
| EP1788859B1 (fr) | 2004-09-16 | 2014-03-19 | CropDesign N.V. | Evaluation de la croissance d'une racine |
| KR100601972B1 (ko) | 2004-11-03 | 2006-07-18 | 삼성전자주식회사 | 레이저와 비드를 이용한 상 분리에 의한 핵산의 정제 장치및 방법 |
| US20060205040A1 (en) | 2005-03-03 | 2006-09-14 | Rangarajan Sampath | Compositions for use in identification of adventitious viruses |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| WO2007014045A2 (fr) | 2005-07-21 | 2007-02-01 | Isis Pharmaceuticals, Inc. | Procede pour l'identification et la quantification rapide de variants d'acide nucleique |
| EP2064332B1 (fr) | 2006-09-14 | 2012-07-18 | Ibis Biosciences, Inc. | Procédé d'amplification ciblée de génome entier pour l'identification d'agents pathogènes |
| US8871471B2 (en) | 2007-02-23 | 2014-10-28 | Ibis Biosciences, Inc. | Methods for rapid forensic DNA analysis |
| US9598724B2 (en) | 2007-06-01 | 2017-03-21 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| US8148163B2 (en) | 2008-09-16 | 2012-04-03 | Ibis Biosciences, Inc. | Sample processing units, systems, and related methods |
| WO2010031780A1 (fr) * | 2008-09-16 | 2010-03-25 | Basf Plant Science Gmbh | Procédé de sélection des plantes |
| WO2010033599A2 (fr) | 2008-09-16 | 2010-03-25 | Ibis Biosciences, Inc. | Cartouches de mélange, postes de mélange et kits, systèmes et procédés associés |
| EP2344893B1 (fr) | 2008-09-16 | 2014-10-15 | Ibis Biosciences, Inc. | Systèmes et procédés de manipulation de microplaques |
| US8158936B2 (en) | 2009-02-12 | 2012-04-17 | Ibis Biosciences, Inc. | Ionization probe assemblies |
| WO2011008972A1 (fr) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Systèmes pour l'identification d'un bioagent |
| WO2011008971A1 (fr) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Appareil de levage et de montage |
| US9890408B2 (en) | 2009-10-15 | 2018-02-13 | Ibis Biosciences, Inc. | Multiple displacement amplification |
| CN102533731A (zh) * | 2012-01-19 | 2012-07-04 | 西北农林科技大学 | 一种番茄基因组总dna提取试剂盒及其提取方法 |
| CN102618532A (zh) * | 2012-05-02 | 2012-08-01 | 易春 | 基于磁珠法从植物叶片中提取基因组dna的试剂盒及其提取方法 |
| CN110452905B (zh) * | 2019-08-22 | 2023-06-02 | 云南省烟草农业科学研究院 | 一种提高烟草dna沉淀效率的提取方法及其应用 |
| CN110669759A (zh) * | 2019-10-28 | 2020-01-10 | 北京百迈客生物科技有限公司 | 一种适用于纳米孔测序的真菌高纯度长片段基因组dna提取方法 |
| CN112921028A (zh) * | 2019-12-06 | 2021-06-08 | 深圳华大基因科技服务有限公司 | Dna纯化方法、基因组dna的提取方法、测序方法和试剂盒 |
| CN115856285B (zh) * | 2022-12-27 | 2025-06-24 | 太原理工大学 | 一种绿色制备免表面修饰的磁性粒子增强型生物分子检测方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997932A (en) * | 1989-11-13 | 1991-03-05 | Boehringer Mannheim Corporation | Method and kit for purifying nucleic acids |
| GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| US5981235A (en) * | 1996-07-29 | 1999-11-09 | Promega Corporation | Methods for isolating nucleic acids using alkaline protease |
| CN1230440C (zh) * | 1997-12-06 | 2005-12-07 | Dna研究创新有限公司 | 核酸的分离 |
-
2000
- 2000-04-21 JP JP2000612441A patent/JP2002541839A/ja not_active Withdrawn
- 2000-04-21 WO PCT/US2000/010834 patent/WO2000063362A1/fr not_active Ceased
- 2000-04-21 EP EP00923575A patent/EP1171584A1/fr not_active Withdrawn
- 2000-04-21 AU AU43675/00A patent/AU4367500A/en not_active Abandoned
- 2000-04-21 CA CA002370656A patent/CA2370656A1/fr not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0063362A1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102888397A (zh) * | 2012-09-25 | 2013-01-23 | 杭州硕航生物科技有限公司 | 一种利用磁珠提取全血基因组dna的试剂盒及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002541839A (ja) | 2002-12-10 |
| AU4367500A (en) | 2000-11-02 |
| WO2000063362A1 (fr) | 2000-10-26 |
| CA2370656A1 (fr) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000063362A1 (fr) | Kit d'extraction d'adn magnetique pour plantes | |
| US7931920B2 (en) | Method for the isolation of nucleic acids from any starting material | |
| US5783686A (en) | Method for purifying nucleic acids from heterogenous mixtures | |
| JP5390772B2 (ja) | 核酸を安定化試薬から精製するための組成物および方法 | |
| DE4321904B4 (de) | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen | |
| EP1088064B1 (fr) | Procede simple et rapide d'isolement d'acides nucleiques circulaires | |
| US7285651B2 (en) | Process for the scaleable purification of plasmid DNA | |
| US8029991B2 (en) | Method and formulation for the extraction of nucleic acids from any complex starting materials | |
| EP1560926B1 (fr) | Nouvelles formulations de tampons pour isoler, purifier et recuperer des acides nucleiques a chaine longue et a chaine courte | |
| EP1687424A1 (fr) | Procede rapide et economique pour l'isolement d' acides nucleiques | |
| CA2393479C (fr) | Procede de purification evolutive d'adn plasmidique | |
| CN113265395A (zh) | 菌体裂解液澄清试剂以及在质粒提取工艺中的应用 | |
| KR100622606B1 (ko) | 단일공정에 의한 플라스미드 dna 정제용 조성물과 그를이용하여 플라스미드 dna를 정제하는 방법 | |
| JP3811767B6 (ja) | 均質な混合物から核酸を純化する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20011108 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20021101 |